Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3880948019 | Crizanlizumab-containing product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3880949010 | Product containing crizanlizumab in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4759721000052119 | läkemedel som innehåller krizanlizumab, parenteral läkemedelsform | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Crizanlizumab-containing product in parenteral dose form | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
| Crizanlizumab-containing product in parenteral dose form | Has active ingredient | Crizanlizumab (substance) | true | Inferred relationship | Some | 1 | |
| Crizanlizumab-containing product in parenteral dose form | Is a | Product containing crizanlizumab (medicinal product) | true | Inferred relationship | Some | ||
| Crizanlizumab-containing product in parenteral dose form | Is a | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only crizanlizumab in parenteral dose form (medicinal product form) | Is a | True | Crizanlizumab-containing product in parenteral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR